Sciences

The MarketWatch news department was not involved in the creation of this content. Feb. 09, 2023 (The Expresswire) – "Analysis of the impact of COVID-19 on the industry will be added to the final report." Global "Life Sciences Market" 2023-2028 provides comprehensive and high-quality information on innovative business growth strategies, macro and micro economic factors, … Read more

Bangor – Bay University is pleased to offer a number of Health Science degrees. The course starts on February 27. Health science is a relatively new academic discipline, according to an article in US News. Although many universities do not have well-established health science programs, there are many reasons to consider pursuing a health science … Read more

Left to right: Gary Tischler and Richard Coles of the Vanburton Group together at 3 West 29th Street (Getty, Vanburton Group, Google Maps) One of New York's most anticipated office projects certainly seems to be changing. The VanBurton Group is considering developing its vacant lot next to Marble Collegiate Church at West 29th Street and … Read more

Today, early detection of cancer is much more common than it was ten years ago. Exact Sciences ( NASDAQ:EXAS ) can't claim all the credit, but the non-invasive cancer tests it sells play an important role. About 4 million people will be screened for cancer by the company in 2021. Despite its product's large audience, … Read more

As 2023 begins, following a trend professionals in The Woodlands, Texas and the greater Houston area are just beginning to see, some are seeing a number of announcements from companies relocating or expanding their presence in the region, including some from California. According to the Woodlands Area Economic Development Partnership, as of 2019, The Woodlands … Read more

Urovant Sciences announces its partnership with Holly Robinson Peet, actress and OAB patient, as part of the Time To Go™ campaign, an OAB awareness program. The Time to Go campaign aims to highlight the impact the disease can have on patients and present options for managing OAB symptoms so that people living with OAB feel … Read more

Exact Sciences (EXAS) closed the last trading day at $67.92, down 0.67% from the previous trading session. The move was smaller than the S&P 500's 1.56% decline for the day. Elsewhere, the Dow lost 1.81% while the Tech-Nasdaq lost 4.66%. The molecular diagnostics company's shares were up 33.84% month-on-month today. Meanwhile, the medical sector was … Read more

text size Cancer testing company Exact Sciences did not expect to report the results until the September quarter. But test seller Cologuard said sales growth in the December quarter helped boost profits earlier than expected. Sunday in Madison, Wisconsin. Revenue rose 28% to more than $550 million in the last quarter of 2022, according to … Read more